

9:00 am EST - 3:30 pm EST
Past Event
9:00 am - 3:30 pm EST
1775 Massachusetts Ave., NW
Washington, DC
The U.S. Food and Drug Administration (FDA) is developing the capacity for active medical product surveillance, which will enhance the agency’s ability to monitor the safety of marketed medical products. This new capacity will come in the form of the Sentinel System, which is currently being piloted through a project known as Mini-Sentinel. Accomplishing the goals of active medical product surveillance will require further development of new and existing methods and tools.
On February 16, the Engelberg Center for Health Care Reform hosted a one-day expert workshop to discuss some of the most pressing methodological issues facing active medical product safety surveillance. At this workshop, experts from academia, the private sector, FDA and other government agencies discussed several topics, including:
Matthew Fiedler
January 31, 2025
Richard G. Frank
January 30, 2025
Rachel Sachs, Richard G. Frank
January 29, 2025